RU2009123361A - METHOD FOR TREATING TOBACCO DEPENDENCE IN MEN - Google Patents
METHOD FOR TREATING TOBACCO DEPENDENCE IN MEN Download PDFInfo
- Publication number
- RU2009123361A RU2009123361A RU2009123361/14A RU2009123361A RU2009123361A RU 2009123361 A RU2009123361 A RU 2009123361A RU 2009123361/14 A RU2009123361/14 A RU 2009123361/14A RU 2009123361 A RU2009123361 A RU 2009123361A RU 2009123361 A RU2009123361 A RU 2009123361A
- Authority
- RU
- Russia
- Prior art keywords
- composite
- sessions
- systems
- duration
- session
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 11
- 208000025569 Tobacco Use disease Diseases 0.000 title claims abstract 7
- 239000002131 composite material Substances 0.000 claims abstract 14
- 230000001800 adrenalinergic effect Effects 0.000 claims abstract 6
- 230000003291 dopaminomimetic effect Effects 0.000 claims abstract 6
- 239000003862 glucocorticoid Substances 0.000 claims abstract 6
- 230000001632 homeopathic effect Effects 0.000 claims abstract 6
- 235000013305 food Nutrition 0.000 claims abstract 5
- 230000000742 histaminergic effect Effects 0.000 claims abstract 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims abstract 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 claims abstract 4
- 230000001548 androgenic effect Effects 0.000 claims abstract 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract 4
- 230000036515 potency Effects 0.000 claims abstract 4
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims abstract 2
- QADHLRWLCPCEKT-UHFFFAOYSA-N Androstenediol Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)O)C4C3CC=C21 QADHLRWLCPCEKT-UHFFFAOYSA-N 0.000 claims abstract 2
- QADHLRWLCPCEKT-LOVVWNRFSA-N androst-5-ene-3beta,17beta-diol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC=C21 QADHLRWLCPCEKT-LOVVWNRFSA-N 0.000 claims abstract 2
- 229950009148 androstenediol Drugs 0.000 claims abstract 2
- 229960003638 dopamine Drugs 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 229960005309 estradiol Drugs 0.000 claims abstract 2
- 229930182833 estradiol Natural products 0.000 claims abstract 2
- 229940011871 estrogen Drugs 0.000 claims abstract 2
- 239000000262 estrogen Substances 0.000 claims abstract 2
- 230000001076 estrogenic effect Effects 0.000 claims abstract 2
- 229960001340 histamine Drugs 0.000 claims abstract 2
- 230000000391 smoking effect Effects 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Способ лечения табачной зависимости у мужчин, заключающийся в том, что осуществляют воздействие на эстрогенную, андрогенную, адренергическую, дофаминергическую, глюкокортикоидную, гистаминергическую и пищевую биологически активные системы организма методом биорезонансной терапии с использованием соответствующего для каждой системы гомеопатического препарата: эстрадиол-композита, андростендиол-композита, адреналин-композита, дофамин-композита, глюкокортикоид-композита, гистамин-композита в сотых гомеопатических потенциях и никотин-композита в двухсотых гомеопатических потенциях, при этом воздействие осуществляют билатерально или гомолатерально с левой стороны на все или отдельные ручные и ножные меридианы пациентки, причем длительность воздействия на каждую биологически активную систему составляет 3 мин, продолжительность сеанса терапии от 10 до 30 мин, количество сеансов терапии на курс лечения - 6-15 сеансов. ! 2. Способ по п.1, отличающийся тем, что первый сеанс биорезонансной терапии проводят через 1-2 ч после последнего курения. ! 3. Способ по п.2, отличающийся тем, что при диссоциированной форме табачной зависимости осуществляют воздействие на адренергическую, дофаминергическую и глюкокортикоидную системы гомолатерально с левой стороны, на эстрогенную, гистаминергическую и пищевую системы билатерально с обеих сторон, продолжительность сеанса 18 мин, количество сеансов на курс лечения - 6-8 сеансов. ! 4. Способ по п.2, отличающийся тем, что при психосоматической форме табачной зависимости осуществляют воздействие андрогенную, адренергическую и дофаминергическую системы гомолатерально с левой стор 1. A method of treating tobacco dependence in men, which consists in the effect on estrogen, androgenic, adrenergic, dopaminergic, glucocorticoid, histaminergic and food biologically active systems of the body by the method of bioresonance therapy using the corresponding homeopathic preparation for each system: estradiol composite, androstenediol composite, adrenaline composite, dopamine composite, glucocorticoid composite, histamine composite in hundredth homeopathic potencies and nickname tin-composite in two hundred homeopathic potencies, while the exposure is performed bilaterally or homolaterally on the left side on all or individual patient’s manual and foot meridians, and the duration of exposure to each biologically active system is 3 minutes, the duration of the treatment session is from 10 to 30 minutes, the number treatment sessions per treatment course - 6-15 sessions. ! 2. The method according to claim 1, characterized in that the first session of bioresonance therapy is carried out 1-2 hours after the last smoking. ! 3. The method according to claim 2, characterized in that, in the case of a dissociated form of tobacco dependence, they affect the adrenergic, dopaminergic and glucocorticoid systems homolaterally on the left side, the estrogenic, histaminergic and food systems bilaterally on both sides, session duration 18 min, number of sessions for the course of treatment - 6-8 sessions. ! 4. The method according to claim 2, characterized in that, in the psychosomatic form of tobacco dependence, the androgenic, adrenergic and dopaminergic systems are exposed to the left side homolaterally
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009123361/14A RU2428164C2 (en) | 2009-06-19 | 2009-06-19 | Method of treating tobacco addiction in men |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009123361/14A RU2428164C2 (en) | 2009-06-19 | 2009-06-19 | Method of treating tobacco addiction in men |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009123361A true RU2009123361A (en) | 2010-12-27 |
| RU2428164C2 RU2428164C2 (en) | 2011-09-10 |
Family
ID=44055303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009123361/14A RU2428164C2 (en) | 2009-06-19 | 2009-06-19 | Method of treating tobacco addiction in men |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2428164C2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| RU2234954C2 (en) * | 2002-12-27 | 2004-08-27 | Сафаев Раджаб Давронович | Integrated method for treatment of tobacco smoking |
| RU2273469C1 (en) * | 2004-07-23 | 2006-04-10 | Федеральное государственное унитарное предприятие "УРАЛЬСКИЙ ЭЛЕКТРОХИМИЧЕСКИЙ КОМБИНАТ" | Method for treating the cases of tobacco addiction |
-
2009
- 2009-06-19 RU RU2009123361/14A patent/RU2428164C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2428164C2 (en) | 2011-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010300611A8 (en) | Hematopoietic stem cells for use in the treatment of a kidney injury | |
| MX2010006519A (en) | Method for treating bone fracture with anti-sclerostin antibodies. | |
| MX2019013279A (en) | Methods of treating doose syndrome using fenfluramine. | |
| SG161307A1 (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | |
| WO2006127007A3 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
| ZA202106769B (en) | Treatment of ciliopathies | |
| ME02450B (en) | IMPROVED ANTI-TUMOR TREATMENTS | |
| WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
| ZA202304965B (en) | Combination therapy for treating cancer | |
| ATE394097T1 (en) | METHOD OF ADMINISTRATION OF BUPRENORPHINE FOR THE TREATMENT OF DEPRESSION | |
| MX2025003477A (en) | Use of reboxetine to treat narcolepsy | |
| NZ617397A (en) | Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units | |
| RU2009123361A (en) | METHOD FOR TREATING TOBACCO DEPENDENCE IN MEN | |
| GB0405381D0 (en) | A method and means for treating heart failure | |
| MX367580B (en) | Method of threating cancer. | |
| RU2009123360A (en) | METHOD FOR TREATING TOBACCO DEPENDENCE IN WOMEN | |
| HRP20151320T1 (en) | COMPOSITION OF BEE HONEY AND L-ALANYL-L-GLUTAMINE | |
| BR112012011316A2 (en) | tivozanib and temsirolimus in combination | |
| WO2020061067A8 (en) | Compositions and methods for treating bone injury | |
| DK1778834T5 (en) | Methods for the use of regenerative cells in the treatment of renal diseases and disorders | |
| BRPI0507302A (en) | Method and Compositions for the Treatment of Lipodystrophy | |
| UA79616U (en) | Method for rehabilitation of patients with ischemic heart disease | |
| MX2022006630A (en) | Use of reboxetine to treat nervous system disorders. | |
| CN108324797A (en) | A kind of Chinese medicine for treating body odour | |
| MX2024008083A (en) | Compositions and methods for treating epilepsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200620 |